IGFBP2 and cancer: Taking this data together with observations in the cancer literature, we propose a model (Figure 4L) in which Pitpnc1a stimulates the secretion of inhibitory IGFBP2 that acts as an IGF counterbalance onto circuits involved in wakefulness.